http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0095169-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2005-415
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4906
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F5-41
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
filingDate 1983-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1992-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0095169-B1
titleOfInvention Improved penetration enhancers for transdermal drug delivery of systemic agents
abstract A composition for administering systematically active agents through the skin or other body membranes of humans and animals comprising an effective amount of a membrane penetration enhancer having the structural formula <CHEM> where R is H or a lower alkyl group having 1 - 4 carbon atoms, m is 5 - 7 and n is 0 - 17, and a systemically active agent is described. The use of an effective amount of a membrane penetration enhancer having the above mentioned structural formula in a method for administering systemically active agents through the skin or other body membranes of humans and animals in a transdermal device or formulation is also described.
priorityDate 1982-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128530096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9920342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5385498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127501720
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466924110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID347521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10224496
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127474297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18159
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128711862

Total number of triples: 47.